Lecrolyn (Sodium Cromoglicate)

Sodium cromoglicate acts as a mast cell stabilizer. It prevents calcium‑dependent degranulation of mast cells in the conjunctiva, which blocks the release of histamine, leukotrienes, and other inflammatory mediators. This inhibition reduces vascular leakage and nerve irritation, alleviating allergic eye symptoms.

The specific dosing regimen for Lecrolyn is determined by the prescribing clinician. Typically, one drop is instilled in each affected eye two to four times daily, but the exact frequency and duration depend on the severity of the allergy and the patient’s response.

Safety data for sodium cromoglicate in pregnancy and lactation are limited. It should only be used if the potential benefit justifies any possible risk to the fetus or infant. Healthcare providers should evaluate each case individually and discuss alternatives when appropriate.

To place an order, submit an enquiry on the Lecrolyn product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Lecrolyn belongs to the mast cell stabilizer class, whereas many eye allergy drops are antihistamines. Mast cell stabilizers prevent the release of allergic mediators, offering a prophylactic effect, while antihistamines provide rapid symptom relief. In some cases, clinicians combine both types for optimal control.

Lecrolyn should be stored at room temperature, away from direct sunlight and moisture. Keep the bottle tightly closed in its original packaging. Do not freeze the product, and discard any solution that appears discolored or contains particles.

Lecrolyn is applied topically to the eye. After washing hands, tilt the head back, pull down the lower eyelid, and place one drop into the conjunctival sac. Close the eye gently for a few seconds, avoid blinking excessively, and refrain from touching the dropper tip to any surface.

Although rare, serious adverse events can include severe allergic reactions such as eyelid swelling, significant eye pain, sudden vision changes, or corneal ulceration. Patients experiencing any of these symptoms should discontinue use immediately and seek urgent ophthalmologic evaluation.

Lecrolyn is contraindicated in individuals with a known hypersensitivity to sodium cromoglicate or any excipients in the formulation. It should also be avoided in eyes with active infection, severe inflammation of unknown cause, or in patients who have had a recent ocular surgery unless directed by a specialist.